Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 4, 2006, Pages 323-324

  Erikci, Alev Akyol ^a   Ozturk, Ahmet ^a   Sayan, Ozkan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute myeloid leukemia; Recombinant activated factor VII; Uterine bleeding

Indexed keywords

CYTARABINE; DAUNORUBICIN; DESOGESTREL; ETHINYLESTRADIOL; METHYLERGOMETRINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE TRANSFUSION; UTERUS BLEEDING; UTERUS MYOMA; VAGINA BLEEDING;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FACTOR VIIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; LEUKEMIA, MYELOID; RECOMBINANT PROTEINS; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 33646799485     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000224854.88366.05     Document Type: Article

References (15)

1. Shapiro AD. Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors. Semin Thromb Hemost 2000; 26:413-419.
2. Gerotziafas GT, Zervas K, Arzoglou P, Karavaggeli E, Parashou S, Van Dreden P, et al. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation. Br J Haematol 2002; 117:705-708.
3. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002; 32 (Suppl 1):41-46.
4. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002; 30:975-978.
5. Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O. Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. Blood Coagul Fibrinolysis 2005; 16:145-147.
6. Hoffman M, Monroe DM 3rd, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9 (Suppl 1):61-65.
7. Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26:373-377.
8. Das P, Carcao M, Hitzler J. Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. Pediatr Blood Cancer 2005 (Epub ahead of print).
9. Zulfikar B, Kayran SM. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven). Blood Coagul Fibrinolysis 2004; 15:261-263.
10. Zver S, Andoljsek D, Cernelc P. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. Eur J Haematol 2004; 72:455-456.
11. Osborne W, Bhandari S, Tait RC, Franklin IM. Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia. Clin Lab Haematol 2004; 26:229-231.
12. Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 2002; 69:219-222.
13. Udvardy M, Telek B, Mezey G, Batar P, Altorjay I. Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer). Blood Coagul Fibrinolysis 2004; 15:265-267.
14. Meijer K, de Graaff WE, Daenen SM, van der Meer J. Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIa. Arch Intern Med 2000; 160:2216-2217.
15. Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant 2001; 28:405-407.